Jean‐Paul Cano

1.0k citations
39 papers · 919 indexed · h-index 18

Impact in

    • Pharmacogenetics and Drug Metabolism
  • Oncology top 10%
    • Cancer Treatment and Pharmacology
    • Drug Transport and Resistance Mechanisms

Papers in

Jean‐Paul Cano

39 papers receiving 866 citations

Peers

Jean‐Paul Cano
Comparison fields: 5 of 94
  • Pharmacology 183
  • Oncology 341
  • Analytical Chemistry 77
  • Toxicology 26
  • Cancer Research 87
Replace Peter R. Gwilt with:
Peter R. Gwilt United States
Alain Deroussent France
Janny G.P. Peters Netherlands
Ronald de Vries Belgium
I. Bartošek Italy
J Catalin France
Takenori Takahata Japan
Anne M. Filppula Finland
Satoru Asahi Japan
Gilbert N. Lam United States
Jean‐Paul Cano relative to Peter R. Gwilt United States Peter R. Gwilt's profile →
Citations per field
00.5×4.1×
Peter R. Gwilt · 1×
Citations per year

Countries citing papers authored by Jean‐Paul Cano

Since Specialization
Citations

This map shows the geographic impact of Jean‐Paul Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Paul Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Paul Cano more than expected).

Fields of papers citing papers by Jean‐Paul Cano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Paul Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Paul Cano. The network helps show where Jean‐Paul Cano may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jean‐Paul Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jean‐Paul Cano Line = papers co-authored together Jean‐Paul Cano links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20144
2 20041
3 200213
4 200041
5 199942
6 19994
7 199212
8 199117
9 199130
10 199035
11 198958
12 19892
13 198889
14 19888
15 198712
16 19855
17 198516
18 198517
19 198319
20 19837

About Jean‐Paul Cano

Jean‐Paul Cano is a scholar working on Pharmacology, Toxicology, Oncology, Analytical Chemistry and Transplantation, having authored 39 papers that have together received 919 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Pharmacogenetics and Drug Metabolism (5 papers), Cancer therapeutics and mechanisms (4 papers), Analytical Methods in Pharmaceuticals (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Pharmacology (183 citations), Oncology (341 citations), Analytical Chemistry (77 citations), Toxicology (26 citations) and Cancer Research (87 citations). Jean‐Paul Cano has collaborated with scholars based in France, Switzerland and Italy. Frequent co-authors include Roger Rahmani, Jacques Barbet, Claude Aubert, Gérard Fabre, Philippe Coassolo, Laurence Vian, Marie Martin, Roger Favre, René Bruno and Athanassios Iliadis. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Biochemical Pharmacology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, International Journal of Cancer and Clinica Chimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026